Rate My Professor Gough Au

Au's research specializations include oncolytic virotherapy, virology, and cancer biology. With over 18 years of experience in academic and industry settings, he advanced picornavirus research and the development of novel oncolytic viruses for human cancers during his role as Director of Research and Development at Viralytics Ltd from 2011 to 2019. More recently, as Senior Research Consultant and Project Manager at CSIRO's Australian Centre for Disease Preparedness, his work has centered on zoonotic and emerging viruses, including Risk Group 4 pathogens such as filoviruses and henipaviruses. He contributed to developing a ferret model for SARS-CoV-2 and preclinical testing of vaccine candidates amid the COVID-19 pandemic. Key publications encompass 'Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia' (2026, Emerging Infectious Diseases), 'Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination' (2024, Veterinary Microbiology), 'SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell-derived human neurons' (2024, Journal of Neurovirology), 'The swan genome and transcriptome, it is not all black and white' (2023, Genome Biology), and 'Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma' (2007, British Journal of Haematology).